Open Access

Clinical scenario 2: Identifying patients eligible for extended VTE treatment: Insights from EINSTEIN CHOICE and EINSTEIN EXT.


Congress Presentation

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
25 presentations
1 follower

6 more presentations in this session

Welcome and introduction.

Speaker: Professor S. Konstantinides (Mainz, DE)


Clinical scenario 1: Anticoagulation for patients with pulmonary embolism from hospital to home: Insights from the 2019 ESC PE guideline updates and HOT-PE trial.

Speaker: Professor S. Konstantinides (Mainz, DE)


Clinical scenario 3: Interpreting the evidence base for rivaroxaban in the treatment of cancer-associated thrombosis: What does it mean for your patient?

Speaker: Professor A. Khorana


Access the full session

Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios

Speakers: Doctor J. Weitz, Professor S. Konstantinides, Professor S. Konstantinides, Professor A. Khorana

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb